Sens. Nelson, Kerry Argue Against Device Fee In Health Reform Bill
This article was originally published in The Gray Sheet
Executive Summary
Two Democratic senators last week made high-profile declarations against the $40 billion, 10-year device industry fee included in the health care reform bill that passed out of the Senate Finance Committee Oct. 13
You may also be interested in...
MDMA Opposes Any Health Reform Device Fee, Even A Reduced One
The Medical Device Manufacturers Association says it is opposed to any targeted medical device tax in health reform legislation, and would not support even a reduced version of the $4-billion-per-year fee currently proposed in the Senate Finance Committee's bill
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.